Par Health Issues Third U.S. Recall in a Month for IV Blood Thinner Due to Particulate Contamination

U.S.-based generic drugmaker Par Health has issued a voluntary recall of 22 lots of argatroban injection, an IV blood thinner, due to potential contamination with various particulates including cellulose, polystyrene, and stainless steel. This marks the company's third product recall in a month, following similar issues with other infused drugs. The affected lots were distributed to wholesalers and hospitals between December 30, 2024, and May 5, 2026. While no adverse events have been reported to date, particulate-contaminated injections can be life-threatening, potentially causing pulmonary emboli or other vascular occlusions. Wholesalers and hospital pharmacies are advised to immediately discontinue use of the recalled product.